ArticleFrontiers in psychiatry2026
Shifting the paradigm in bipolar disorder: moving beyond conventional inflammatory markers to novel EBI3-containing heterodimeric cytokines.
Junfang Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.